0001365916-16-000160.txt : 20160715 0001365916-16-000160.hdr.sgml : 20160715 20160715191739 ACCESSION NUMBER: 0001365916-16-000160 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160713 FILED AS OF DATE: 20160715 DATE AS OF CHANGE: 20160715 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMYRIS, INC. CENTRAL INDEX KEY: 0001365916 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5885 HOLLIS ST SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-0761 MAIL ADDRESS: STREET 1: 5885 HOLLIS ST SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: AMYRIS BIOTECHNOLOGIES INC DATE OF NAME CHANGE: 20060613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DUYK GEOFFREY M CENTRAL INDEX KEY: 0001202090 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34885 FILM NUMBER: 161770482 MAIL ADDRESS: STREET 1: 301 COMMERCE STREET STREET 2: SUITE 3300 CITY: FORT WORTH STATE: TX ZIP: 76102 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-07-13 0001365916 AMYRIS, INC. AMRS 0001202090 DUYK GEOFFREY M C/O AMYRIS, INC. 5885 HOLLIS STREET, SUITE 100 EMERYVILLE CA 94608 1 0 0 0 Common Stock 2016-07-13 4 A 0 17000 0 A 29000 D Stock Option (Right to Buy) .41 2016-07-13 4 A 0 26000 0 A 2026-07-13 Common Stock 26000 26000 D Represents a restricted stock unit award that vests as to 100% of the units subject to the award on July 13, 2017. Stock option vests as to 100% of the total number of shares subject to the option on July 13, 2017. /s/ Geoffrey M. Duyk by Stephen Dobson, Attorney-in-Fact 2016-07-15 EX-24 2 poa-duyk.htm POWER OF ATTORNEY

POWER OF ATTORNEY





 KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints

Chris Jaenike, Stephen Dobson, Vincent Fontanilla and Nanette Agustines, each with power to act without

the others, his or her true and lawful attorney-in-fact to:



 (1) execute for and on behalf of the undersigned, in the undersigned's capacity as a director

and/or officer of Amyris, Inc. (the "Company"), any and all Form ID filings, Forms 3, 4

and 5 reports and any amendments thereto required to be filed by the undersigned in

accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules and

regulations thereunder with respect to transactions in Company securities;



 (2) do and perform any and all acts for and on behalf of the undersigned which may be

necessary or desirable to complete and execute any such Form ID filings, Forms 3, 4 and

5 reports and any amendments thereto and timely file such forms with the United States

Securities and Exchange Commission and any stock exchange or similar authority; and



 (3) take any other action which, in the opinion of such attorney-in-fact, may be of benefit to,

in the best interest of, or legally required by, the undersigned in connection with the

foregoing powers.



 The undersigned hereby grants to each such attorney-in-fact full power and authority to do and

perform any and every act and thing whatsoever requisite, or proper to be done in the exercise of any of

the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or

could do if personally present, with full power of substitution or revocation, hereby ratifying and

confirming all that any such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall

lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein

granted.  The undersigned acknowledges that each such attorney-in-fact, in serving in such capacity at the

request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned's

responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.



 This Power of Attorney (i) supersedes any and all prior powers of attorney granted by the

undersigned with respect to the powers granted above, and (ii) shall remain in full force and effect until

the undersigned is no longer required to file Forms 3, 4 or 5 with respect to the undersigned's holdings of

and transactions in Company securities, unless earlier revoked by the undersigned in a signed writing

delivered to any of the foregoing attorneys-in-fact.



 IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed

as of this 11 day of July, 2016.





By:   /s/ Geoffrey Duyk

  Geoffrey Duyk